Search

Author/Creator Bhattacharya, Mondira

1. An Innovative, Collaborative, and Strategic Approach to Proactively Evaluate and Update Drug Interactions Based on Prescribing Information of Newly Approved Medicinal Products. (November 2017)

Authors:
Porcalla, Ariel; Barshteyn, Nella; Snyder, Scott; Bhattacharya, Mondira
Journal:
Therapeutic innovation & regulatory science
Issue:
Volume 51:Number 6(2017:Nov.)
Page Start:
780
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 10253 (12th September 2020)

Authors:
Olivotto, Iacopo; Oreziak, Artur; Barriales-Villa, Roberto; Abraham, Theodore P; Masri, Ahmad; Garcia-Pavia, Pablo; Saberi, Sara; Lakdawala, Neal K; Wheeler, Matthew T; Owens, Anjali; Kubanek, Milos; Wojakowski, Wojciech; Jensen, Morten K; Gimeno-Blanes, Juan; Afshar, Kia; Myers, Jonathan; Hegde,...
Journal:
Lancet
Issue:
Volume 396:Issue 10253(2020)
Page Start:
759
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Practical Analysis and Visualization Tools for Benefit-Risk Assessment in Drug Development: A Review of Recent FDA Advisory Committee Meeting Packages. (1st October 2016)

Authors:
Wen, Shihua; He, Weili; Evans, Scott R.; Quartey, George; Norton, Jonathan D.; Chuang-Stein, Christy; Jiang, Qi; Ma, Haijun; Bhattacharya, Mondira
Journal:
Statistics in biopharmaceutical research
Issue:
Volume 8:Number 4(2016)
Page Start:
409
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗